Core Insights - Nuclear stocks have risen significantly, with China National Nuclear Power (02302) up 9.67% to HKD 4.31 and China General Nuclear Power (01164) up 7.84% to HKD 3.3 [1] - A recent report from JPMorgan highlights a growing market tension between the explosive demand driven by nuclear energy revival and AI revolution, and the supply bottlenecks caused by major producers reducing output and geopolitical factors [1] - Uranium spot and futures prices have increased by approximately 5% this year, driven by production cuts from major suppliers like Kazatomprom and Cameco, alongside strong demand from China's rapid nuclear power construction and AI data centers [1] Supply and Demand Dynamics - Morgan Stanley's report indicates significant changes in the global uranium market, with evolving supply-demand dynamics making the market outlook increasingly favorable [1] - The optimistic price outlook is supported by tightening supply, stable spot demand, and an increase in potential contract volumes, alongside structural support from the nuclear energy revival [1] - Morgan Stanley projects uranium prices to reach USD 87 per pound by Q4 2025, reflecting a solid fundamental backdrop for the uranium market with further upward price potential [1]

Core Viewpoint - Nuclear stocks have risen significantly, driven by a combination of increasing demand from nuclear energy revival and AI revolution, alongside supply constraints from major producers [1] Group 1: Market Performance - China National Nuclear Corporation International (02302) increased by 9.67%, reaching 4.31 HKD; China General Nuclear Power Corporation (01164) rose by 7.84%, reaching 3.3 HKD [1] Group 2: Supply and Demand Dynamics - A report from JPMorgan highlights a tightening market reality, with uranium spot and futures prices rising approximately 5% this year due to reduced production from major suppliers like Kazatomprom and Cameco [1] - The rapid construction of nuclear power plants in China and the substantial electricity demand from AI data centers are driving strong growth in uranium demand [1] Group 3: Future Price Outlook - Morgan Stanley indicates that the global uranium market is undergoing significant changes, with a positive price outlook due to tightening supply and strong demand [1] - Uranium prices are expected to reach 87 USD per pound by Q4 2025, supported by supply challenges, stable spot demand, and an increase in potential contract volumes [1] - The structural support from the "nuclear energy revival" contributes to a solid fundamental outlook for the uranium market, indicating further price upside potential [1]

Industry Investment Rating - The industry investment rating is maintained at "Outperform the Market" [1] Core Viewpoints - The report highlights that the recent Congo export policy for cobalt is expected to drive prices upward, with a significant reduction in export quotas leading to increased demand for replenishment from downstream enterprises [6] - The report suggests a bullish outlook for precious metals following the recent FOMC meeting, despite some market adjustments, indicating a potential slow bull market for gold [4] - Copper prices are anticipated to break through key resistance levels, supported by seasonal demand increases in China [5] - The aluminum market is expected to see price increases due to rising downstream consumption as the National Day holiday approaches [5] - Lithium demand is projected to grow significantly, driven by a major contract signed by CATL for lithium iron phosphate materials, indicating a strong outlook for lithium prices [7] - Uranium prices are expected to rise due to potential export restrictions from Russia, which could significantly impact global supply [8] Summary by Sections Industry Overview - The closing index for the industry is at 6522.39, with a weekly high of 6795.38 and a low of 3912.76 [1] Price Movements - Basic metals saw declines: copper down 1.19%, aluminum down 1.33%, zinc down 2.88%, lead down 0.17%, and tin down 1.53%. Precious metals had mixed results with gold down 0.22% and silver up 1.13% [21] Inventory Levels - Global visible inventories increased for copper by 7945 tons, aluminum by 8010 tons, and zinc by 2724 tons, while lead saw a decrease of 4085 tons [29]

中期報告 Interim Report 2025 Contents 目錄 | Corporate Information | 公司資料 | 2 | | --- | --- | --- | | Highlights of Interim Results | 中期業績摘要 | 5 | | Business Review and Analysis | 業務表現及分析 | 6 | | Business Prospect | 業務展望 | 17 | | Financial Review and Financial Capital | 財務表現與財務資本 | 18 | | Disclosure of Interests | 權益披露 | 29 | | Other Information | 其他資料 | 32 | | Report on Review of Condensed Interim Consolidated | 簡明中期綜合財務報表審閱報告 | 35 | | Financial Statements | | | | Condensed Interim Consolidated Statement of Prof ...

Group 1 - The Hang Seng Index rose by 0.07%, gaining 19 points to close at 26,465 points, while the Hang Seng Tech Index increased by 0.39% [1] - The early trading volume in Hong Kong stocks reached 160.2 billion HKD [1] Group 2 - New pharmaceutical stocks in the Hong Kong Stock Connect saw significant gains, with ZhiJie AnKang-B (02617) surging over 49%, reaching a market capitalization of over 240 billion HKD; BaiZe Medical (02609) rose over 76%; and TongYuanKang Pharmaceutical-B (02410) increased by over 36% [1] - Fosen Pharmaceutical (01652) experienced a dramatic rise of over 410%, closing at 1.35 HKD, up 297%, following the approval of Metformin and Ertugliflozin tablets [2] - Shanghai Fudan (01385) increased by 5.87%, with the company well-prepared for supply chain disruptions, and Morgan Stanley noted limited impact on demand [2] - SF Express (09699) rose over 6% as its "SoFast" service officially launched in Macau, with Daiwa optimistic about the company's revenue growth prospects [2] - Valiant Bio-B (09887) increased by over 13%, with its core product LBL-024 for melanoma completing its first patient dosing in trials [2] - Bilibili-W (09626) rose by 2.78%, accumulating a total increase of about 25% over the past six days, with the new game "Three Kingdoms: Hundred Generals" set for testing in October [2] - LionTeng Holdings (02562) surged over 7% as it plans to acquire leading companies in artificial intelligence and blockchain to expand its digital finance layout [2] - GCL-Poly Energy (03800) rose by 3.97%, planning a discounted placement to raise approximately 5.392 billion HKD for structural adjustments in polysilicon capacity [2] - China General Nuclear Power Corporation Mining (01164) increased by 6.7%, as the U.S. seeks to expand its strategic uranium reserves, with institutions expecting a recovery in uranium prices [2] - Yunfeng Financial (00376) fell over 16% after announcing a discounted placement to raise about 1.15 billion HKD [2]

Market Overview - The Hang Seng Index rose by 0.07%, gaining 19 points to close at 26,465 points, while the Hang Seng Tech Index increased by 0.39% [1] - Early trading volume in Hong Kong stocks reached HKD 160.2 billion [1] Notable Stock Movements - New pharmaceutical stocks in the Hong Kong Stock Connect surged, with Yaojie Ankang-B (02617) rising over 49%, reaching a market capitalization of over HKD 240 billion [1] - Baize Medical (02609) saw an increase of over 76% [1] - Tongyuan Kang Pharmaceutical-B (02410) rose by over 36% [1] Specific Company Highlights - Fosen Pharmaceutical (01652) experienced a dramatic rise of over 410%, closing at HKD 1.35, up 297%, following the approval of Metformin and Ertugliflozin tablets [2] - Shanghai Fudan (01385) increased by 5.87%, with the company prepared for supply chain disruptions, and Morgan Stanley noted limited impact on demand [2] - SF Express (09699) rose by over 6% as its "SoFast" service launched in Macau, with positive revenue growth prospects according to Daiwa [2] - Valiant Pharmaceuticals-B (09887) increased by over 13%, completing the first medication trial for its core product LBL-024 for melanoma [2] - Bilibili-W (09626) rose by 2.78%, accumulating a 25% increase over six days, with the new game "Three Kingdoms: Hundred Generals" set for testing in October [2] - Liontech Holdings (02562) surged over 7% as it plans to acquire a leading AI and blockchain company to expand its digital finance footprint [2] - GCL-Poly Energy (03800) rose by 3.97%, planning a discounted share placement to raise approximately HKD 5.392 billion for structural adjustments in polysilicon capacity [2] - CGN Mining (01164) increased by 6.7% amid expectations of rising uranium prices as the U.S. seeks to expand its strategic uranium reserves [2] - Yunfeng Financial (00376) fell over 16% after announcing a discounted share placement to raise about HKD 1.15 billion [2]

Core Viewpoint - The article highlights significant movements in the Hong Kong and US stock markets, focusing on specific companies and their recent performance, driven by various strategic announcements and market conditions. Hong Kong Stock Market Summary - China General Nuclear Power Corporation (01164) rose over 6% following US Energy Secretary Chris Wright's suggestion to consider expanding strategic uranium reserves, indicating potential upward price adjustments for uranium [1] - Yunfeng Financial (00376) fell over 18% after announcing a rights issue at a discount of approximately 16.8%, aiming to raise about HKD 1.15 billion [1] - GCL-Poly Energy Holdings (03800) increased over 2% as it plans a rights issue at a discount of about 8.73%, targeting net proceeds of HKD 5.392 billion for structural adjustments in polysilicon production [1] - Lion Group Holding (02562) surged over 6% after signing a letter of intent to acquire a leading AI and blockchain company, expanding its digital finance footprint [1] - Pharmaron Beijing Co., Ltd. (02617) skyrocketed over 53% after being included in the Hong Kong Stock Connect list, with a cumulative increase of nearly 10 times since its inclusion, and northbound investors adding over HKD 300 million in two days [1] - Anta Sports Products (02020) rose over 2% as retail sales of sports goods showed rapid growth in the first eight months, indicating marginal improvement in sales [1] - SF Technology (09699) increased over 5% after launching its "SoFast" brand in Macau, marking a significant step in its overseas business expansion [1] - Shanghai Fudan (01385) rose over 6% as Morgan Stanley reported the company is well-prepared for supply chain disruptions, with limited demand impact expected [2] - Tianyue Advanced (02631) increased over 1% after being included in the Hong Kong Stock Connect, with silicon carbide expected to see new market growth [2] - Valiant Co., Ltd. (09887) rose over 10% after announcing the completion of the first patient dosing in a trial for its core product LBL-024 for melanoma [2] US Stock Market Summary - Tesla (TSLA.US) rose 3.56% as the head of its German factory announced an increase in production plans for Q3 and Q4 due to strong sales data [3] - NVIDIA (NVDA.US) fell 0.04% as it faces further investigation for violating antitrust laws [3] - Hesai Technology (HSAI.US) increased 4.31% after announcing a partnership with a leading US Robotaxi company, securing over USD 40 million in lidar orders [3] - XPeng Motors (XPEV.US) rose 2.20% after formalizing a deep cooperation with Magna Steyr in Austria, marking the start of local production in Europe [3] - NIO (NIO.US) increased 4.34% as it announced the NIO Day 2025 event, scheduled for September 20, where the new ES8 will be launched [3] - Apple (AAPL.US) rose 1.12% as Morgan Stanley reported that demand for the iPhone 17 series exceeded that of the previous year's iPhone 16 series during its first week of launch [4] - Fangdd Network Group (DUO.US) fell 9.17% following the National Bureau of Statistics' report indicating a decline in residential property prices in August [3] - Alibaba (BABA.US) rose 1.92% ahead of the 2025 Cloud Summit scheduled for September 24-26 in Hangzhou [4] - ASML Holding (ASML.US) increased 6.56% after announcing a EUR 1.3 billion investment in French AI startup Mistral AI, becoming its largest shareholder [4] - Bilibili (BILI.US) rose 6.40% as it announced the upcoming public test of its new strategy card game, "Three Kingdoms: Hundred Generals Card" [4] - Oracle (ORCL.US) increased 3.41% as management disclosed that its cloud infrastructure revenue is set to experience steep growth [4]

Core Viewpoint - China General Nuclear Power Corporation (CGN) Mining (01164.HK) experienced a significant stock price increase of over 7%, closing at 2.85 HKD with a trading volume of 134 million HKD [2] Group 1 - CGN Mining's stock rose by 7.55% on September 16 [2] - The closing price of CGN Mining's stock was reported at 2.85 HKD [2] - The total trading volume for CGN Mining reached 134 million HKD [2]

Group 1 - China General Nuclear Power Corporation (CGN) Mining (01164) saw a stock increase of over 7%, specifically 7.55%, reaching HKD 2.85 with a trading volume of HKD 134 million [1] - U.S. Energy Secretary Chris Wright suggested that the U.S. should consider expanding its strategic uranium reserves to reduce dependence on Russian supplies and enhance confidence in the long-term prospects of nuclear power [1] - According to Zheshang Securities, the global trend of nuclear power recovery remains unchanged, and the supply-demand tightness in the natural uranium market has not eased, indicating a potential upward correction in spot uranium prices [1] Group 2 - The company, as a specialized uranium resource development and operation platform under CGN Group, is expected to expand its resource portfolio alongside the group's increasing nuclear power installed capacity [1] - The current cycle of rising natural uranium prices is anticipated to lead to simultaneous growth in both volume and price for the company [1]

Group 1 - The core viewpoint of the article highlights the positive market response for China General Nuclear Power Corporation (CGN) Mining, with a stock increase of over 7% following comments from the U.S. Energy Secretary regarding the expansion of strategic uranium reserves to reduce reliance on Russian supplies and boost confidence in the long-term prospects of nuclear power [1] - The report from Zheshang Securities indicates that the global nuclear power recovery trend remains unchanged, and the tight supply-demand dynamics in the natural uranium market have not eased, suggesting a potential upward correction in spot uranium prices [1] - The company, as a specialized uranium resource development and operation platform under CGN Group, is expected to benefit from the group's increasing nuclear power installed capacity, leading to growth in both volume and price during the current natural uranium upcycle [1]